Infant Survival Everywhere) (recruiting) Clinical Trial IMPAACT 1058A: Intensive , MD CFAP Research Pharmacokinetics of Newer Agents in Pharmacokinetic Studies of New Children/Youth. Classes of Antiretroviral Drug combinations in Children, Adolescents and Young Adults (recruiting) Clinical Trial IMPAACT 1066: A Phase I/II, , MD CFAP Research Raltegravir in Children Multicenter, Open-Label, Pharmacokinetics Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Raltegravir (MK-0518) in HIV-1 Infected Children and Adolescents (recruiting) Clinical Trial IMPAACT A5240: A Phase II Study , MD CFAP Research HPV in Adult HIV positive females to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1 Infected Females (recruiting) Clinical Trial IMPAACT A5241: The Optimized , MD CFAP Research Salvage Antiretroviral Therapy (ART) Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1 Infected Treatment- Subjects Using the cPss to Select an Effective Regimen (recruiting)
Infant Survival Everywhere) (recruiting) Clinical Trial IMPAACT 1058A: Intensive Pharmacokinetic Studies of New Classes of Antiretroviral Drug combinations in Children, Adolescents and Young Adults (recruiting) , MD CFAP Research Pharmacokinetics of Newer Agents in Children/Youth. Clinical Trial IMPAACT 1066: A Phase I/II, Multicenter, Open-Label, Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Raltegravir (MK-0518) in HIV-1 Infected Children and Adolescents (recruiting) , MD CFAP Research Raltegravir in Children Pharmacokinetics Clinical Trial IMPAACT A5240: A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1 Infected Females (recruiting) , MD CFAP Research HPV in Adult HIV positive females Clinical Trial IMPAACT A5241: The Optimized Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1 Infected Subjects Using the cPss to Select an Effective Regimen (recruiting) , MD CFAP Research Salvage Antiretroviral Therapy (ART) Treatment-
12-31-12%20FCHAR%20Inventory.docx